How long should I wait to see the results of Soliris?

Written by Inês Martins, PhD |

Category: Soliris

In the REGAIN trial, which supported Soliris’ approval for myasthenia gravis, the majority of patients responded to treatment and experienced clinically meaningful improvements in the first three months. However, each patient is unique and may respond differently to the medication. A discussion with a healthcare provider can help patients understand how Soliris may help in their specific case.